Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy

Cornea

Volumn 25, Issue 9, 2006, Pages 1100-1101

  Richards, J C ^a   Wiffen, Steven J ^a,b,c  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c LIONS EYE INSTITUTE   (Australia)

Author keywords

Alendronate; Bisphosphonate; Cornea; Transplant rejection; Uveitis

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; BETAXOLOL; CALCIUM; CEFTAZIDIME; CHLORAMPHENICOL; INDAPAMIDE; OFLOXACIN; PERINDOPRIL; PREDNISOLONE; PREDNISOLONE ACETATE; QUININE; STEROID; VALACICLOVIR; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; CORNEA EDEMA; CORNEA TRANSPLANTATION; DRUG USE; DRUG WITHDRAWAL; ENDOPHTHALMITIS; EYE INFLAMMATION; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GRAFT REJECTION; HUMAN; HYPERTENSION; HYPOPYON; INTRAOCULAR INFLAMMATION; KERATOPATHY; MUSCLE CRAMP; OSTEOPOROSIS; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PSEUDOPHAKIA; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; SYMPTOM; UVEITIS; VISUAL ACUITY;

AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; FEMALE; GRAFT REJECTION; HUMANS; KERATOPLASTY, PENETRATING; OSTEOPOROSIS, POSTMENOPAUSAL; UVEITIS;

EID: 33845371043     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000225713.00630.e5     Document Type: Article

References (11)

1. Frith J, Rogers M. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro. J Bone Miner Res. 2003;18:204-212.
2. Bauer D, Mrzyk S, Van Rooijen N, et al. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp Eye Res. 2001;72:261-269.
3. Mbekeani J, Slamovits T, Schwartz B, et al. Ocular inflammation associated with alendronate therapy. Arch Ophthalmol. 1999;117:837-838.
4. Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol. 2003;135:219-222.
5. Sauty A, Pecherstorfer M, Zimmer-Roth I, et al. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone. 1996;18:133-139.
6. Fietta P, Manganelli P, Lodigiani L. Clodronate induced uveitis. Ann Rheum Dis. 2003;62:378.
7. Baatz H, Puchta J, Reszka R, et al. Macrophage depletion prevents leukocyte adhesion and disease induction in experimental melanin-protein induced uveitis. Exp Eye Res. 2001;73:101-109.
8. Broekhuyse R, Huitinga I, Kuhlmann E, et al. Differential effect of macrophage depletion on two forms of experimental uveitis evoked by pigment epithelial membrane protein (EAPU), and by melanin-protein (EMIU). Exp Eye Res. 1997;65:841-848.
9. Slegers T, Van Rooijen N, Van Rij G, et al. Delayed graft rejection in prevascularised corneas after subconjunctival injection of clodronate liposomes. Curr Eye Res. 2000;20:322-324.
10. Van Der Veen G, Broersma L, Dijkstra C, et al. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest Ophthalmol Vis Sci. 1994;35:3505-3515.
11. Cheng H, Tumpey T, Staats H, et al. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci. 2000;46:1402-1409.